TipRanks
Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289)
:2289
Hong Kong Market
2289
Charmacy Pharmaceutical Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2289 full AI Analyst Report?

Charmacy Pharmaceutical Co., Ltd. Class H (2289) Ratios

0 Followers

Charmacy Pharmaceutical Co., Ltd. Class H Ratios

HK:2289's free cash flow for Q2 2026 was ¥0.07. For the 2026 fiscal year, HK:2289's free cash flow was decreased by ¥ and operating cash flow was ¥0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.09 1.09 1.09 1.07 1.09
Quick Ratio
 0.81 0.84 0.85 0.78 0.83
Cash Ratio
 0.16 0.23 0.20 0.24 0.22
Solvency Ratio
 0.02 0.02 0.03 0.03 0.05
Operating Cash Flow Ratio
 0.10 0.08 0.04 -0.04 0.02
Short-Term Operating Cash Flow Coverage
 0.16 0.13 0.06 -0.07 0.04
Net Current Asset Value
¥ 222.34M¥ 217.39M¥ 192.04M¥ 162.15M¥ 190.96M
Leverage Ratios
Debt-to-Assets Ratio
 0.53 0.53 0.49 0.42 0.41
Debt-to-Equity Ratio
 3.45 3.39 2.74 2.30 1.99
Debt-to-Capital Ratio
 0.78 0.77 0.73 0.70 0.67
Long-Term Debt-to-Capital Ratio
 0.06 0.06 0.02 0.00 0.00
Financial Leverage Ratio
 6.48 6.42 5.59 5.43 4.82
Debt Service Coverage Ratio
 0.06 0.06 0.08 0.09 0.07
Interest Coverage Ratio
 1.72 1.11 1.21 1.62 3.46
Debt to Market Cap
 4.09 2.92 1.66 1.05 1.77
Interest Debt Per Share
 19.89 19.92 16.28 13.10 11.30
Net Debt to EBITDA
 11.48 8.78 7.28 5.41 5.72
Profitability Margins
Gross Profit Margin
7.24%7.66%7.32%6.65%6.43%
EBIT Margin
2.69%3.00%3.05%2.46%2.24%
EBITDA Margin
2.91%3.47%3.51%3.11%2.90%
Operating Profit Margin
2.09%1.55%1.65%1.50%2.91%
Pretax Profit Margin
1.42%1.47%1.61%1.53%2.92%
Net Profit Margin
1.01%1.06%1.20%1.17%2.17%
Continuous Operations Profit Margin
1.01%1.06%1.20%1.17%2.17%
Net Income Per EBT
71.09%71.95%74.85%76.16%74.12%
EBT Per EBIT
67.67%94.43%97.20%101.85%100.44%
Return on Assets (ROA)
1.20%1.17%1.54%1.58%3.16%
Return on Equity (ROE)
7.70%7.50%8.61%8.59%15.22%
Return on Capital Employed (ROCE)
14.79%10.03%10.96%10.53%19.91%
Return on Invested Capital (ROIC)
2.58%1.80%2.37%2.56%5.12%
Return on Tangible Assets
1.22%1.19%1.58%1.62%3.26%
Earnings Yield
9.29%6.54%5.36%4.05%13.77%
Efficiency Ratios
Receivables Turnover
 3.05 3.44 3.58 4.51 4.83
Payables Turnover
 8.46 7.92 10.60 6.24 4.46
Inventory Turnover
 4.81 5.08 6.27 5.30 6.66
Fixed Asset Turnover
 16.56 14.88 13.97 13.40 14.20
Asset Turnover
 1.19 1.11 1.28 1.36 1.46
Working Capital Turnover Ratio
 16.77 16.82 20.41 22.02 29.19
Cash Conversion Cycle
 152.22 131.82 125.74 91.38 48.55
Days of Sales Outstanding
 119.50 106.11 101.94 81.02 75.64
Days of Inventory Outstanding
 75.84 71.82 58.24 68.89 54.83
Days of Payables Outstanding
 43.13 46.11 34.44 58.52 81.92
Operating Cycle
 195.35 177.93 160.18 149.90 130.47
Cash Flow Ratios
Operating Cash Flow Per Share
 2.94 2.51 0.98 -0.89 0.41
Free Cash Flow Per Share
 2.89 2.44 0.84 -1.27 0.33
CapEx Per Share
 0.06 0.07 0.15 0.38 0.08
Free Cash Flow to Operating Cash Flow
 0.98 0.97 0.85 1.42 0.81
Dividend Paid and CapEx Coverage Ratio
 52.58 3.08 1.33 -0.83 1.19
Capital Expenditure Coverage Ratio
 52.58 36.25 6.74 -2.36 5.13
Operating Cash Flow Coverage Ratio
 0.15 0.13 0.06 -0.07 0.04
Operating Cash Flow to Sales Ratio
 0.07 0.06 0.02 -0.02 0.01
Free Cash Flow Yield
61.56%37.25%9.09%-10.83%5.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.91 15.23 18.65 24.70 7.26
Price-to-Sales (P/S) Ratio
 0.11 0.16 0.22 0.29 0.16
Price-to-Book (P/B) Ratio
 0.84 1.15 1.61 2.12 1.11
Price-to-Free Cash Flow (P/FCF) Ratio
 1.62 2.68 11.01 -9.23 18.53
Price-to-Operating Cash Flow Ratio
 1.59 2.61 9.37 -13.14 14.92
Price-to-Earnings Growth (PEG) Ratio
 -2.46 -1.24 8.95 -0.58 0.02
Price-to-Fair Value
 0.84 1.15 1.61 2.12 1.11
Enterprise Value Multiple
 15.20 13.43 13.67 14.67 11.15
Enterprise Value
 2.07B 2.04B 2.13B 2.01B 1.35B
EV to EBITDA
 15.20 13.43 13.67 14.67 11.15
EV to Sales
 0.44 0.47 0.48 0.46 0.32
EV to Free Cash Flow
 6.63 7.76 23.56 -14.62 38.07
EV to Operating Cash Flow
 6.50 7.54 20.07 -20.81 30.64
Tangible Book Value Per Share
 4.94 5.02 5.00 4.77 4.70
Shareholders’ Equity Per Share
 5.61 5.71 5.73 5.54 5.50
Tax and Other Ratios
Effective Tax Rate
 0.29 0.28 0.25 0.24 0.26
Revenue Per Share
 43.32 40.60 41.07 40.77 38.66
Net Income Per Share
 0.44 0.43 0.49 0.48 0.84
Tax Burden
 0.71 0.72 0.75 0.76 0.74
Interest Burden
 0.53 0.49 0.53 0.62 1.31
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.04 0.04 <0.01 0.03 0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 6.81 5.40 1.99 -1.88 0.49
Currency in CNY